Published in J Cereb Blood Flow Metab on July 02, 2008
Baby STEPS: a giant leap for cell therapy in neonatal brain injury. Pediatr Res (2011) 2.02
Human neural stem cell grafts modify microglial response and enhance axonal sprouting in neonatal hypoxic-ischemic brain injury. Stroke (2010) 1.44
Mannitol facilitates neurotrophic factor up-regulation and behavioural recovery in neonatal hypoxic-ischaemic rats with human umbilical cord blood grafts. J Cell Mol Med (2010) 1.29
Multipotent adult progenitor cells prevent macrophage-mediated axonal dieback and promote regrowth after spinal cord injury. J Neurosci (2011) 1.25
Intranasal mesenchymal stem cell treatment for neonatal brain damage: long-term cognitive and sensorimotor improvement. PLoS One (2013) 1.12
Update on stem cell therapy for cerebral palsy. Expert Opin Biol Ther (2011) 1.09
Therapeutic effects of hMAPC and hMSC transplantation after stroke in mice. PLoS One (2012) 1.00
Stem cell recruitment of newly formed host cells via a successful seduction? Filling the gap between neurogenic niche and injured brain site. PLoS One (2013) 0.98
Cell Therapy From Bench to Bedside Translation in CNS Neurorestoratology Era. Cell Med (2010) 0.96
Intravenous Bone Marrow Stem Cell Grafts Preferentially Migrate to Spleen and Abrogate Chronic Inflammation in Stroke. Stroke (2015) 0.94
Pharmacological neuroprotection after perinatal hypoxic-ischemic brain injury. Curr Neuropharmacol (2010) 0.93
Mesenchymal stem cell-based treatments for stroke, neural trauma, and heat stroke. Brain Behav (2016) 0.89
Stem cell therapy for neonatal hypoxic-ischemic encephalopathy. Front Neurol (2014) 0.89
Mesenchymal stem cells induce T-cell tolerance and protect the preterm brain after global hypoxia-ischemia. PLoS One (2013) 0.88
Pathophysiology of perinatal asphyxia: can we predict and improve individual outcomes? EPMA J (2011) 0.85
Neuroprotective Strategies after Neonatal Hypoxic Ischemic Encephalopathy. Int J Mol Sci (2015) 0.84
Neurological disorders and the potential role for stem cells as a therapy. Br Med Bull (2012) 0.83
Therapeutic outcomes of transplantation of amniotic fluid-derived stem cells in experimental ischemic stroke. Front Cell Neurosci (2014) 0.82
Human cord blood for the hypoxic-ischemic neonate. Pediatr Res (2012) 0.82
ADVANCES IN THE CELL-BASED TREATMENT OF NEONATAL HYPOXIC-ISCHEMIC BRAIN INJURY. Future Neurol (2013) 0.82
Cortical region-specific engraftment of embryonic stem cell-derived neural progenitor cells restores axonal sprouting to a subcortical target and achieves motor functional recovery in a mouse model of neonatal hypoxic-ischemic brain injury. Front Cell Neurosci (2013) 0.82
Developments in intracerebral stem cell grafts. Expert Rev Neurother (2015) 0.81
Stem cell-paved biobridge facilitates neural repair in traumatic brain injury. Front Syst Neurosci (2014) 0.81
Intranasal administration of human MSC for ischemic brain injury in the mouse: in vitro and in vivo neuroregenerative functions. PLoS One (2014) 0.81
Stem cell-paved biobridges facilitate stem transplant and host brain cell interactions for stroke therapy. Brain Res (2015) 0.78
Neuronal cell reconstruction with umbilical cord blood cells in the brain hypoxia-ischemia. Iran Biomed J (2015) 0.77
A possible new focus for stroke treatment - migrating stem cells. Expert Opin Biol Ther (2015) 0.76
Recent Advances in Stem Cell-Based Therapeutics for Stroke. Transl Stroke Res (2016) 0.76
Multipotent adult progenitor cells on an allograft scaffold facilitate the bone repair process. J Tissue Eng (2016) 0.76
Neuroinflammatory signals enhance the immunomodulatory and neuroprotective properties of multipotent adult progenitor cells. Stem Cell Res Ther (2015) 0.75
Multipotent adult progenitor cells for hypoxic-ischemic injury in the preterm brain. J Neuroinflammation (2015) 0.75
Therapy for Cerebral Palsy by Human Umbilical Cord Blood Mesenchymal Stem Cells Transplantation Combined With Basic Rehabilitation Treatment: A Case Report. Glob Pediatr Health (2015) 0.75
Regulated and Unregulated Clinical Trials of Stem Cell Therapies for Stroke. Transl Stroke Res (2017) 0.75
Advancing critical care medicine with stem cell therapy and hypothermia for cerebral palsy. Neuroreport (2013) 0.75
Stem Cell-Induced Biobridges as Possible Tools to Aid Neuroreconstruction after CNS Injury. Front Cell Dev Biol (2017) 0.75
IGF1R(+) Dental Pulp Stem Cells Enhanced Neuroplasticity in Hypoxia-Ischemia Model. Mol Neurobiol (2016) 0.75
Therapeutic benefit of intravenous administration of bone marrow stromal cells after cerebral ischemia in rats. Stroke (2001) 6.61
The influence of immaturity on hypoxic-ischemic brain damage in the rat. Ann Neurol (1981) 5.33
Central nervous system entry of peripherally injected umbilical cord blood cells is not required for neuroprotection in stroke. Stroke (2004) 2.49
Elevated body swing test: a new behavioral parameter for rats with 6-hydroxydopamine-induced hemiparkinsonism. J Neurosci (1995) 1.88
Neurological emergencies: acute stroke. J Neurol Neurosurg Psychiatry (2000) 1.62
Plasticity and remodeling of brain. J Neurol Sci (2007) 1.49
The neuroblast and angioblast chemotaxic factor SDF-1 (CXCL12) expression is briefly up regulated by reactive astrocytes in brain following neonatal hypoxic-ischemic injury. BMC Neurosci (2005) 1.38
Behavioral and histological characterization of intrahippocampal grafts of human bone marrow-derived multipotent progenitor cells in neonatal rats with hypoxic-ischemic injury. Cell Transplant (2006) 1.10
Neural differentiation and incorporation of bone marrow-derived multipotent adult progenitor cells after single cell transplantation into blastocyst stage mouse embryos. Cell Transplant (2003) 1.05
Cerebral ischemia and CNS transplantation: differential effects of grafted fetal rat striatal cells and human neurons derived from a clonal cell line. Neuroreport (1998) 1.04
Declining diagnosis of birth asphyxia in California: 1991-2000. Pediatrics (2004) 1.00
Limitations of intravenous human bone marrow CD133+ cell grafts in stroke rats. Brain Res (2005) 0.93
Transplantation of fetal neocortex ameliorates sensorimotor and locomotor deficits following neonatal ischemic-hypoxic brain injury in rats. Exp Neurol (1997) 0.89
Transplantation of cryopreserved human bone marrow-derived multipotent adult progenitor cells for neonatal hypoxic-ischemic injury: targeting the hippocampus. Rev Neurosci (2006) 0.87
Exploring the functional landscape of gene expression: directed search of large microarray compendia. Bioinformatics (2007) 3.59
A simple, assumption-free, and clinically interpretable approach for analysis of modified Rankin outcomes. Stroke (2012) 2.57
Remote ischemic perconditioning is effective alone and in combination with intravenous tissue-type plasminogen activator in murine model of embolic stroke. Stroke (2012) 2.46
Remote evaluation of acute ischemic stroke: reliability of National Institutes of Health Stroke Scale via telestroke. Stroke (2003) 2.17
T cell responses to allogeneic human mesenchymal stem cells: immunogenicity, tolerance, and suppression. J Biomed Sci (2005) 2.07
SDF-1 (CXCL12) is upregulated in the ischemic penumbra following stroke: association with bone marrow cell homing to injury. J Neuropathol Exp Neurol (2004) 1.94
Targets for vascular protection after acute ischemic stroke. Stroke (2004) 1.88
Identification of a novel extracellular cation-sensing G-protein-coupled receptor. J Biol Chem (2005) 1.86
Postischemic brain injury is exacerbated in mice lacking the kinin B2 receptor. Hypertension (2006) 1.80
Matrix metalloproteinase-9 in an exploratory trial of intravenous minocycline for acute ischemic stroke. Stroke (2011) 1.80
Minocycline up-regulates Bcl-2 and protects against cell death in mitochondria. J Biol Chem (2004) 1.79
Predicting gene function in a hierarchical context with an ensemble of classifiers. Genome Biol (2008) 1.78
Minocycline to improve neurologic outcome in stroke (MINOS): a dose-finding study. Stroke (2010) 1.69
Delayed minocycline inhibits ischemia-activated matrix metalloproteinases 2 and 9 after experimental stroke. BMC Neurosci (2006) 1.69
VEGFR1/CXCR4-positive progenitor cells modulate local inflammation and augment tissue perfusion by a SDF-1-dependent mechanism. J Mol Med (Berl) (2008) 1.67
Who's in favor of translational cell therapy for stroke: STEPS forward please? Cell Transplant (2009) 1.60
Transplantation of human neural stem cells exerts neuroprotection in a rat model of Parkinson's disease. J Neurosci (2006) 1.59
Menstrual blood cells display stem cell-like phenotypic markers and exert neuroprotection following transplantation in experimental stroke. Stem Cells Dev (2010) 1.51
Improving modified Rankin Scale assessment with a simplified questionnaire. Stroke (2010) 1.50
Hospital volume as a surrogate for laparoscopically assisted colectomy. Surg Endosc (2009) 1.48
Low dose intravenous minocycline is neuroprotective after middle cerebral artery occlusion-reperfusion in rats. BMC Neurol (2004) 1.47
Intravenous multipotent adult progenitor cell therapy for traumatic brain injury: preserving the blood brain barrier via an interaction with splenocytes. Exp Neurol (2010) 1.42
Optimal delivery of minocycline to the brain: implication for human studies of acute neuroprotection. Exp Neurol (2004) 1.40
Bone marrow grafts restore cerebral blood flow and blood brain barrier in stroke rats. Brain Res (2004) 1.40
Pathophysiology and treatment of stroke in sickle-cell disease: present and future. Lancet Neurol (2006) 1.39
The neuroblast and angioblast chemotaxic factor SDF-1 (CXCL12) expression is briefly up regulated by reactive astrocytes in brain following neonatal hypoxic-ischemic injury. BMC Neurosci (2005) 1.38
Cell-based therapy in ischemic stroke. Expert Rev Neurother (2008) 1.33
Rural-urban differences in acute stroke management practices: a modifiable disparity. Arch Neurol (2008) 1.33
Therapeutic targets and limits of minocycline neuroprotection in experimental ischemic stroke. BMC Neurosci (2009) 1.33
Long-term upregulation of inflammation and suppression of cell proliferation in the brain of adult rats exposed to traumatic brain injury using the controlled cortical impact model. PLoS One (2013) 1.33
Wharton's jelly-derived mesenchymal stem cells: phenotypic characterization and optimizing their therapeutic potential for clinical applications. Int J Mol Sci (2013) 1.31
Minocycline and tissue-type plasminogen activator for stroke: assessment of interaction potential. Stroke (2009) 1.30
Severity of controlled cortical impact traumatic brain injury in rats and mice dictates degree of behavioral deficits. Brain Res (2009) 1.27
Multipotent adult progenitor cells prevent macrophage-mediated axonal dieback and promote regrowth after spinal cord injury. J Neurosci (2011) 1.25
Microglia activation as a biomarker for traumatic brain injury. Front Neurol (2013) 1.23
Minocycline for short-term neuroprotection. Pharmacotherapy (2006) 1.23
The impact of incomplete knowledge on evaluation: an experimental benchmark for protein function prediction. Bioinformatics (2009) 1.21
Directing experimental biology: a case study in mitochondrial biogenesis. PLoS Comput Biol (2009) 1.20
Emerging roles for multipotent, bone marrow-derived stromal cells in host defense. Blood (2012) 1.20
A telestroke network enhances recruitment into acute stroke clinical trials. Stroke (2010) 1.19
Simplified modified rankin scale questionnaire: reproducibility over the telephone and validation with quality of life. Stroke (2011) 1.19
Notch-induced rat and human bone marrow stromal cell grafts reduce ischemic cell loss and ameliorate behavioral deficits in chronic stroke animals. Stem Cells Dev (2009) 1.18
Hematopoietic origin of glomerular mesangial cells. Blood (2002) 1.17
Toward cell therapy using placenta-derived cells: disease mechanisms, cell biology, preclinical studies, and regulatory aspects at the round table. Stem Cells Dev (2010) 1.17
Teleneurology applications: Report of the Telemedicine Work Group of the American Academy of Neurology. Neurology (2013) 1.17
Hypertension after experimental cerebral ischemia: candesartan provides neurovascular protection. J Hypertens (2006) 1.17
Intravenous multipotent adult progenitor cell therapy after traumatic brain injury: modulation of the resident microglia population. J Neuroinflammation (2012) 1.15
Neural progenitor NT2N cell lines from teratocarcinoma for transplantation therapy in stroke. Prog Neurobiol (2008) 1.15
Potential of stem/progenitor cells in treating stroke: the missing steps in translating cell therapy from laboratory to clinic. Regen Med (2008) 1.13
Minocycline development for acute ischemic stroke. Transl Stroke Res (2011) 1.12
Human umbilical cord blood cell grafts for brain ischemia. Cell Transplant (2009) 1.12
The immunology of traumatic brain injury: a prime target for Alzheimer's disease prevention. J Neuroinflammation (2012) 1.12
Behavioral and histological characterization of intrahippocampal grafts of human bone marrow-derived multipotent progenitor cells in neonatal rats with hypoxic-ischemic injury. Cell Transplant (2006) 1.10
Update on stem cell therapy for cerebral palsy. Expert Opin Biol Ther (2011) 1.09
A web-based telestroke system facilitates rapid treatment of acute ischemic stroke patients in rural emergency departments. J Emerg Med (2008) 1.09
Remote evaluation of acute ischemic stroke in rural community hospitals in Georgia. Stroke (2004) 1.08
Sex-independent neuroprotection with minocycline after experimental thromboembolic stroke. Exp Transl Stroke Med (2011) 1.07
Underutilization of therapy for hepatocellular carcinoma in the medicare population. Cancer (2010) 1.06
Cyclosporine-A as a neuroprotective agent against stroke: its translation from laboratory research to clinical application. Neuropeptides (2011) 1.06
Kallikrein gene transfer protects against ischemic stroke by promoting glial cell migration and inhibiting apoptosis. Hypertension (2003) 1.05
Does increasing insurance improve outcomes for US cancer patients? J Surg Res (2013) 1.05
Intravenous grafts of amniotic fluid-derived stem cells induce endogenous cell proliferation and attenuate behavioral deficits in ischemic stroke rats. PLoS One (2012) 1.05
Human artificial chromosomes with alpha satellite-based de novo centromeres show increased frequency of nondisjunction and anaphase lag. Mol Cell Biol (2003) 1.04
Transplantation of bone marrow-derived stem cells: a promising therapy for stroke. Cell Transplant (2007) 1.04
Quantitative analyses of matrix metalloproteinase activity after traumatic brain injury in adult rats. Brain Res (2009) 1.02
Cell therapy for stroke: emphasis on optimizing safety and efficacy profile of endothelial progenitor cells. Curr Pharm Des (2012) 1.01
Alcohol exposure as a risk factor for adverse outcomes in elective surgery. J Gastrointest Surg (2010) 1.01
Yeast metabolic and signaling genes are required for heat-shock survival and have little overlap with the heat-induced genes. Proc Natl Acad Sci U S A (2013) 1.01
Amnion: a potent graft source for cell therapy in stroke. Cell Transplant (2009) 1.01
Tactics for vascular protection after acute ischemic stroke. Pharmacotherapy (2005) 1.01
The treatment of neurodegenerative disorders using umbilical cord blood and menstrual blood-derived stem cells. Cell Transplant (2010) 1.00
Kallikrein protects against ischemic stroke by inhibiting apoptosis and inflammation and promoting angiogenesis and neurogenesis. Hum Gene Ther (2006) 0.99
Stem cell therapy for cerebral palsy. Expert Opin Biol Ther (2003) 0.99
Recent Studies Assessing the Proliferative Capability of a Novel Adult Stem Cell Identified in Menstrual Blood. Open Stem Cell J (2011) 0.99
Stem cell recruitment of newly formed host cells via a successful seduction? Filling the gap between neurogenic niche and injured brain site. PLoS One (2013) 0.98
Amniotic fluid as a rich source of mesenchymal stromal cells for transplantation therapy. Cell Transplant (2010) 0.97